Courtesy of Benzinga.
Analysts at Credit Suisse upgraded Thoratec (NASDAQ: THOR) from Neutral to Outperform.
The price target for Thoratec has been raised from $27.00 to $35.00.
Thoratec shares have dropped 30.46% over the past 52 weeks, while the S&P 500 index has surged 14.18% in the same period.
Thoratec’s shares fell 2.01%to close at $29.20 yesterday.
Latest Ratings for THOR
Date | Firm | Action | From | To |
---|---|---|---|---|
Nov 2014 | Credit Suisse | Upgrades | Neutral | Outperform |
Nov 2014 | Wells Fargo | Upgrades | Market Perform | Outperform |
Nov 2014 | Bank of America | Maintains | Neutral |
View More Analyst Ratings for THOR
View the Latest Analyst Ratings
Posted-In: Credit SuisseUpgrades Analyst Ratings